UCDC: Predicting Disease Severity in Males with Ornithine Transcarbamylase Deficiency
7 de nov. de 2022 ·
2m 2s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on October 10, 2022,...
mostra más
New research from the Urea Cycle Disorders Consortium (UCDC). This summary is based on a paper published in the journal Annals of Clinical and Translational Neurology on October 10, 2022, titled "Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency."
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51668
Learn more about UCDC: https://www1.rarediseasesnetwork.org/cms/ucdc
mostra menos
Read the paper here: https://onlinelibrary.wiley.com/doi/10.1002/acn3.51668
Learn more about UCDC: https://www1.rarediseasesnetwork.org/cms/ucdc
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comentarios